Gut flora, gut microbiota or gastrointestinal microbiota, is the complex community of microorganisms that live in the gastrointestinal tract, or GI tract, of humans and other animals, even in insects. The composition of gut microbiota is unique to each individual, much like our fingerprints. The human body’s gastrointestinal microbiota can consist of up to tens of trillions of bacteria, where there can even be more than 3 million different genomes of gut microbiota within a single body.
Table of Contents
What is the essential function of the gut microbiota?
The gut flora is as essential for digestion as each important organ of the digestive system, as it can help the body digest certain foods that the stomach and small intestine have not been able to digest, it helps maintain the wholeness of the intestinal mucosa, it helps with the production of some vitamins, and it plays a fundamental role in the immune system by adding a protective effect along the gastrointestinal tract. A healthy and balanced gut microbiota is key to ensuring proper digestive function, however, an imbalance of gut bacteria can affect the function of the digestive system.
Intestinal Barrier Dysfunction Causing Pathogens
The gut is home, both permanently and temporarily, to an exceedingly complex variety of gut flora, or gut microbiota, which also means that it can become an abundant source of potentially pathogenic organisms, toxins and antigens. The interactions involving enteric pathogens and the intestinal epithelium, a layer of cells that forms the luminal surface or lining of both the small and large intestine of the gastrointestinal tract, or GI tract, can often lead to changes in the intestinal barrier, as well as that in fluid and electrolyte transport, and it could also start an inflammatory response in the gastrointestinal tract. Enteric pathogens can affect intestinal barrier function directly, by binding to cell surface molecules and causing changes in tight junction, or TJ, protein expression. Alternatively, pathogens generate toxins and proteases, which can promote cell damage and apoptosis, or programmed cell death, alter epithelial ion transport, including the TJs and the cytoskeleton. Herein, we will provide examples and short descriptions of numerous mechanisms by which pathogens can affect barrier function.
Vibrio Cholera
Vibrio cholera, or V cholera, is a major enteric pathogen which alters intestinal barrier function by interrupting the normal function of TJs, by deregulating intestinal ion and fluid transport and also by causing inflammation in the gastrointestinal tract. A major toxin produced by V cholera is the cytotoxin, hemagglutinin protease (HA/P), a zinc-binding metalloprotease that destroys tight junction proteins and reduces barrier function. Studies of mutant toxin-attenuated strains of Vibrio cholera have identified HA/P as the primary toxin responsible for alterations of TJs and diminished TER in cultured MDCK and T84 cells. In vitro research studies revealed that HA/P breaks the extracellular domain of occludin. This disrupts intracellular occludin-ZO-1 interactions and destabilizes the TJ complex and cytoskeletal structures, resulting in enhanced paracellular permeability.
Another toxin developed by V cholera is zonula occludens toxin, abbreviated as Zot, an enterotoxin that reversibly increases intestinal epithelial permeability, alters the actin cytoskeleton and causes fragmentation of ZO-1 and occludin. Zonula occludens toxin binds into the zonulin receptor on the apical side of the intestinal epithelial cells and triggers phospholipase C, which leads to PKCα-dependent polymerization of the actin cytoskeleton. Actin polymerization is believed to promote cytoskeletal reorganization and the destabilization of TJ complexes. Consistent with this hypothesis, pretreating intestinal epithelial monolayers using PKCα inhibitors averted Zot-induced fluctuations in actin polymerization and permeability. A human homologue for Zot, zonulin, has been identified and found to bind to the same receptor, in order to regulate intestinal permeability. Zonulin is also considered to balance tight junction, or TJ, function and its deregulation has been involved in the development of many inflammatory diseases related to intestinal barrier dysfunction, such as inflammatory bowel disease, or IBD, Type I diabetes and autoimmune diseases.
Enteropathogenic E. Coli (EPEC)
Enteropathogenic E. Coli, or EPEC, is a diarrhea-causing bacteria that affects TJ proteins by adhering directly into the surface of epithelial cells. They form attaching and effacing lesions, characterized by the localized destruction of the adjacent epithelial microvilli and the creation of a pedestal-like structure in the accumulation of cytoskeletal proteins, such as actin, below the site of attachment. EPEC uses a syringe-like type III secretion system to trigger TJ changes in intestinal epithelial ion secretion. Infection of intestinal T84 monolayers with EPEC increased epithelial permeability and has been associated with the destabilization and dissociation of both ZO-1, occludin and claudin-1 tight junction complex from the lateral membrane. The molecular mechanisms related to EPEC-mediated TJ changes are still unknown; however, research studies utilizing pharmacological agents that inhibit MLCK, believe the involvement of the MLCK pathway might be implicated in the procedure.
Clostridium Perfringens
Although several different genomes of gut microbiota have been demonstrated to affect the TJs, the enterotoxin of Clostridium perfringens, or CPE, which is a common cause of food poisoning, directly interacts with and uses TJs as receptors. CPE binds to the extracellular loop of claudins-3 and -4 on the cell surface of enterocytes, forming small protein complexes in the plasma membrane. These complexes promote oligomerization and the formation of larger plasma membranes, which may be connected to increased plasma membrane permeability. Clostridium perfringens also interacts with occludin to promote its removal from the tight junction and redistribution into the cytoplasm. The redistribution of claudins and occludin destabilizes the TJ complex, altering intestinal paracellular permeability. By way of instance, vulnerability of MDCK monolayers to CPE caused a reversible decrease in TER and increase in permeability. Finally, the large CPE and TJ-containing complexes are believed to introduce into the plasma membrane to form a functional pore, which causes Ca2+ influx that triggers host epithelial cell death by apoptosis or oncosis.
In conclusion, gut flora, gut microbiota or gastrointestinal microbiota, are just as essential for digestion as the other important organs of the digestive system. The complex variation of gut microbiota is fundamental towards ensuring proper digestive function, however, some genomes of gut microbiota can cause changes in the TJ complexes, affecting intestinal barrier function and altering intestinal permeability. Understanding which types of bacteria can lead to gastrointestinal disease can help patients and doctors develop a proper treatment plan. Information referenced from the National Center for Biotechnology Information (NCBI) and the National University of Health Sciences. The scope of our information is limited to chiropractic and spinal injuries and conditions. To discuss the subject matter, please feel free to ask Dr. Jimenez or contact us at 915-850-0900 .
By Dr. Alex Jimenez
Additional Topics: Wellness
Overall health and wellness are essential towards maintaining the proper mental and physical balance in the body. From eating a balanced nutrition as well as exercising and participating in physical activities, to sleeping a healthy amount of time on a regular basis, following the best health and wellness tips can ultimately help maintain overall well-being. Eating plenty of fruits and vegetables can go a long way towards helping people become healthy.
TRENDING TOPIC: EXTRA EXTRA: How to Become a Healthier You!
Post Disclaimer
Professional Scope of Practice *
The information herein on "Intestinal Barrier Dysfunction Caused by Pathogens" is not intended to replace a one-on-one relationship with a qualified health care professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional.
Blog Information & Scope Discussions
Our information scope is limited to Chiropractic, musculoskeletal, physical medicines, wellness, contributing etiological viscerosomatic disturbances within clinical presentations, associated somatovisceral reflex clinical dynamics, subluxation complexes, sensitive health issues, and/or functional medicine articles, topics, and discussions.
We provide and present clinical collaboration with specialists from various disciplines. Each specialist is governed by their professional scope of practice and their jurisdiction of licensure. We use functional health & wellness protocols to treat and support care for the injuries or disorders of the musculoskeletal system.
Our videos, posts, topics, subjects, and insights cover clinical matters, issues, and topics that relate to and directly or indirectly support our clinical scope of practice.*
Our office has reasonably attempted to provide supportive citations and has identified the relevant research study or studies supporting our posts. We provide copies of supporting research studies available to regulatory boards and the public upon request.
We understand that we cover matters that require an additional explanation of how it may assist in a particular care plan or treatment protocol; therefore, to further discuss the subject matter above, please feel free to ask Dr. Alex Jimenez, DC, or contact us at 915-850-0900.
We are here to help you and your family.
Blessings
Dr. Alex Jimenez DC, MSACP, RN*, CCST, IFMCP*, CIFM*, ATN*
email: coach@elpasofunctionalmedicine.com
Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Texas DC License # TX5807, New Mexico DC License # NM-DC2182
Licensed as a Registered Nurse (RN*) in Florida
Florida License RN License # RN9617241 (Control No. 3558029)
Compact Status: Multi-State License: Authorized to Practice in 40 States*
Presently Matriculated: ICHS: MSN* FNP (Family Nurse Practitioner Program)
Dr. Alex Jimenez DC, MSACP, RN* CIFM*, IFMCP*, ATN*, CCST
My Digital Business Card
Comments are closed.